Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer
Standard
Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer. / Ding, Hao; Velasco, Carlos; Ye, Huihui; Lindner, Thomas; Grech-Sollars, Matthew; O'Callaghan, James; Hiley, Crispin; Chouhan, Manil D; Niendorf, Thoralf; Koh, Dow-Mu; Prieto, Claudia; Adeleke, Sola.
In: CANCERS, Vol. 13, No. 19, 4742, 22.09.2021.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer
AU - Ding, Hao
AU - Velasco, Carlos
AU - Ye, Huihui
AU - Lindner, Thomas
AU - Grech-Sollars, Matthew
AU - O'Callaghan, James
AU - Hiley, Crispin
AU - Chouhan, Manil D
AU - Niendorf, Thoralf
AU - Koh, Dow-Mu
AU - Prieto, Claudia
AU - Adeleke, Sola
PY - 2021/9/22
Y1 - 2021/9/22
N2 - Magnetic resonance imaging (MRI) has enabled non-invasive cancer diagnosis, monitoring, and management in common clinical settings. However, inadequate quantitative analyses in MRI continue to limit its full potential and these often have an impact on clinicians' judgments. Magnetic resonance fingerprinting (MRF) has recently been introduced to acquire multiple quantitative parameters simultaneously in a reasonable timeframe. Initial retrospective studies have demonstrated the feasibility of using MRF for various cancer characterizations. Further trials with larger cohorts are still needed to explore the repeatability and reproducibility of the data acquired by MRF. At the moment, technical difficulties such as undesirable processing time or lack of motion robustness are limiting further implementations of MRF in clinical oncology. This review summarises the latest findings and technology developments for the use of MRF in cancer management and suggests possible future implications of MRF in characterizing tumour heterogeneity and response assessment.
AB - Magnetic resonance imaging (MRI) has enabled non-invasive cancer diagnosis, monitoring, and management in common clinical settings. However, inadequate quantitative analyses in MRI continue to limit its full potential and these often have an impact on clinicians' judgments. Magnetic resonance fingerprinting (MRF) has recently been introduced to acquire multiple quantitative parameters simultaneously in a reasonable timeframe. Initial retrospective studies have demonstrated the feasibility of using MRF for various cancer characterizations. Further trials with larger cohorts are still needed to explore the repeatability and reproducibility of the data acquired by MRF. At the moment, technical difficulties such as undesirable processing time or lack of motion robustness are limiting further implementations of MRF in clinical oncology. This review summarises the latest findings and technology developments for the use of MRF in cancer management and suggests possible future implications of MRF in characterizing tumour heterogeneity and response assessment.
U2 - 10.3390/cancers13194742
DO - 10.3390/cancers13194742
M3 - SCORING: Review article
C2 - 34638229
VL - 13
JO - CANCERS
JF - CANCERS
SN - 2072-6694
IS - 19
M1 - 4742
ER -